In 2023, the mortality from malignant neoplasms in the US stood at 605.1 thousand deaths. The forecast for 2024 predicts an increase to 607.41 thousand deaths. From 2024 to 2028, projections show a steady rise in mortality figures, reaching 612.57 thousand deaths in 2028. The average compound annual growth rate (CAGR) from 2024 to 2028 is minimal, indicating a slow upward trend.

Key future trends to watch include:

The impact of advancements in cancer treatment and early detection on mortality rates.
Shifts in demographic factors, such as the aging population, that may influence cancer mortality rates.
Potential policy changes and healthcare access impacting cancer outcomes.